Answers are grounded in this paper and cite their sources.
Generative molecular ai enhances drug-like molecule synthesis, indicating advancements in medicinal chemistry workflows.
SynthSense couples generative molecular AI with retrosynthetic reward functions to produce novel, drug-like molecules that are not only feasible to synthesize but aligned with the parallel synthesis workflows of modern medicinal chemistry.
No takes yet. Share an insight, caveat, or question.
Dekleva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: